⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304553 | 0.97 | — | — | |
| SCHEMBL30363497 | 0.94 | — | — | |
| SCHEMBL28101732 | 0.94 | — | — | |
| SCHEMBL11470161 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL28107008 | 0.94 | — | — | |
| SCHEMBL28874017 | 0.94 | — | — | |
| SCHEMBL30230076 | 0.94 | — | — | |
| Pyrimidine SCHEMBL28269751 | 0.79 | MAPT (0.33) | — | |
| SCHEMBL17652127 | 0.76 | CRBN (0.36) | — | |
| Methane SCHEMBL28312214 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112250661-B | Method for catalytically synthesizing lactide | 南京大学 | 2021-11-02 | — | — | CN | claimed |
| CN-112250661-A | Method for catalytically synthesizing lactide | 南京大学 | 2021-01-22 | — | — | CN | claimed |
| CN-112250661-B | Method for catalytically synthesizing lactide | 南京大学 | 2021-11-02 | — | — | CN | disclosed |
| CN-112250661-A | Method for catalytically synthesizing lactide | 南京大学 | 2021-01-22 | — | — | CN | disclosed |
| US-7855191-B2 | Agent having a destructive effect on malignant tumors and method for the production thereof | C.Y.L. PHARMAZEUTIKA GMBH (AT) | 2010-12-21 | — | — | US | disclosed |
| US-20060292218-A1 | Agent having a destructive effect on malignant tumors and method for the production thereof | C.Y.L.PHARMAZEUTIKA GMBH (AT) | 2006-12-28 | — | — | US | disclosed |